Technical / White Paper

Drug Solubility and the Need for Speed

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Lonza Small Molecules, and any views and opinions expressed do not necessarily reflect those of

Drug Solubility and the Need for Speed

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways of improving solubility if the product is to succeed. This also has to be done as quickly and efficiently as possible, with speed of the essence in every drug development program.

This playbook looks at why insolubility is an issue, and the properties that affect solubility.

Latest content from Lonza Small Molecules

show more

Lonza de-risks drug development through PBPK

Paid for and in partnership with Lonza Small Molecules

The opportunity to de-risk drug development through PBPK

No company wants to progress a molecule through to the clinic only to suffer a bad readout. PBPK modeling services allow companies to predict what absorption challenges may arise in trials, and plan ways to mitigate them.

Related resources from Lonza Small Molecules

Supplier info centre